Maestros Electronics Telecommun Systems Ltd vs Medinova Diagnostic Services Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Oct 25, 2026

Key Highlights

The Latest Trading Price of Maestros Electronics & Telecommun. Systems Ltd is ₹ 77.7 as of 23 Oct 15:30 . The P/E Ratio of Maestros Electronics & Telecommun. Systems Ltd changed from 12.2 on March 2024 to 9.2 on March 2026 . This represents a CAGR of -8.98% over 3 yearsThe P/E Ratio of Medinova Diagnostic Services Ltd(Merged) changed from 11.3 on March 2021 to 0 on March 2026 . This represents a CAGR of -100.00% over 6 years The Market Cap of Maestros Electronics & Telecommun. Systems Ltd changed from ₹ 60.31 crore on March 2024 to ₹ 66.4 crore on March 2026 . This represents a CAGR of 3.26% over 3 yearsThe Market Cap of Medinova Diagnostic Services Ltd(Merged) changed from ₹ 22.86 crore on March 2021 to ₹ 0 crore on March 2026 . This represents a CAGR of -100.00% over 6 years The revenue of Maestros Electronics & Telecommun. Systems Ltd for the Jun '26 is ₹ 10.61 crore as compare to the Mar '26 revenue of ₹ 12.81 crore. This represent the decline of -17.17% The revenue of Medinova Diagnostic Services Ltd(Merged) for the Jun '26 is ₹ 0 crore as compare to the Mar '26 revenue of ₹ 0 crore. This represent the decline of 0% The ebitda of Maestros Electronics & Telecommun. Systems Ltd for the Jun '26 is ₹ 2.4 crore as compare to the Mar '26 ebitda of ₹ 3.13 crore. This represent the decline of -23.32% The ebitda of Medinova Diagnostic Services Ltd(Merged) for the Jun '26 is ₹ 0 crore as compare to the Mar '26 ebitda of ₹ 0 crore. This represent the decline of 0% The net profit of Maestros Electronics & Telecommun. Systems Ltd changed from ₹ 1.25 crore to ₹ 1.67 crore over 9 quarters. This represents a CAGR of 13.74% The net profit of Medinova Diagnostic Services Ltd(Merged) changed from ₹ 0.42 crore to ₹ 0 crore over 9 quarters. This represents a CAGR of -100.00% The Dividend Payout of Maestros Electronics & Telecommun. Systems Ltd changed from 22.04 % on March 2022 to 0 % on March 2026 . This represents a CAGR of -100.00% over 5 yearsThe Dividend Payout of Medinova Diagnostic Services Ltd(Merged) changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 years .

About Maestros Electronics & Telecommun. Systems Ltd

Maestros Electronics & Telecommunications Systems Limited was incorporated on February 19, 2010.
At present, Company is engaged in activities pertaining to design, development, and manufacturing of creating products and services for financial inclusion, cardiology, gynecology, critical care patient and diseases management in medicine with rich experience in latest technologies and communication. It provide an advanced portfolio of products and services, including patient monitors, electrocardiographs, defibrillators, pulse oximeters, fetal monitors, stress test systems and much more. With state-of-the-art R&D and manufacturing facilities located in Mumbai, India, Company excel in creating cutting-edge solutions tailored to the needs of clients.
It mainly operates into two segments viz, Electronics & Instrumentation (E&T) and Telemedicine.

About Medinova Diagnostic Services Ltd

Medinova Diagnostic Services Limited (MDSL), incorporated in 1985, commenced business on 26 March, 1993.
It belongs to Standard Organics Group.
The Company is engaged in providing comprehensive range of diagnostic services spanning pathological investigations, radiology & imaging, conventional, specialized lab services and diagnostic cardiology. MDSL has acquired the business and undertaking of the diagnostic services division of Standard Medical & Pharmaceuticals (SMPL) as a going concern together with assets and liabilities from 1 Apr.'93.
It has four main diagnostic centres in Hyderabad, Bangalore, Pune, and Kolkata apart from mini/medium-sized franchise centres at Karimnagar, Mancherial, Vizag, Nellore. MDSL came out with a public issue of 67.50 lac equity shares at par, aggregating Rs 6.

FAQs for the comparison of Maestros Electronics & Telecommun. Systems Ltd and null

Which company has a larger market capitalization, Maestros Electronics & Telecommun. Systems Ltd or Medinova Diagnostic Services Ltd?

Market cap of Maestros Electronics & Telecommun. Systems Ltd is 85 Cr while Market cap of Medinova Diagnostic Services Ltd is 43 Cr

What are the key factors driving the stock performance of Maestros Electronics & Telecommun. Systems Ltd and Medinova Diagnostic Services Ltd?

The stock performance of Maestros Electronics & Telecommun. Systems Ltd and Medinova Diagnostic Services Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Maestros Electronics & Telecommun. Systems Ltd and Medinova Diagnostic Services Ltd?

As of October 25, 2026, the Maestros Electronics & Telecommun. Systems Ltd stock price is INR ₹77.7. On the other hand, Medinova Diagnostic Services Ltd stock price is INR ₹43.45.

How do dividend payouts of Maestros Electronics & Telecommun. Systems Ltd and Medinova Diagnostic Services Ltd compare?

To compare the dividend payouts of Maestros Electronics & Telecommun. Systems Ltd and Medinova Diagnostic Services Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.